Barinthus Biotherapeutics BRNS Balance Sheet (2020-2026)

BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT
Reported Financials

Barinthus Biotherapeutics Quarterly Balance Sheet

Periods 26 quarters
Latest Jun 2026

Barinthus Biotherapeutics reported total assets of $81.89M and total liabilities of $24.76M for the quarter ended Jun 2026, down 36.8% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
233.87M214.05M200.60M192.33M200.10M194.38M191.33M173.03M160.31M142.09M130.00M117.80M106.10M110.66M99.12M86.26M74.27M70.46M65.86M59.30M
Receivables - NetNet Receivables
0.04M0.02M18.01M0.03M0.32M0.17M
Receivables - OtherOther Receivables
5.38M6.23M4.78M17.05M6.15M4.54M2.50M3.14M4.17M4.91M5.20M4.52M14.97M7.14M3.00M4.54M4.63M1.11M1.23M1.28M
Receivables
5.42M6.25M22.79M6.18M4.86M2.67M4.91M5.20M7.14M
Prepaid Assets
6.68M6.46M7.40M11.70M8.25M8.27M5.90M8.26M6.58M9.91M7.96M9.58M8.18M6.20M6.31M7.68M6.34M4.83M4.24M2.36M
Current Assets
245.98M226.76M230.78M226.29M218.62M213.04M200.66M184.78M171.06M156.91M143.13M131.88M134.65M125.74M109.88M100.41M86.78M77.79M72.66M63.27M
Non-Current Assets
Property, Plant & Equipment (Net)
1.03M1.83M4.58M7.04M6.77M7.96M12.71M13.74M12.27M11.82M11.53M10.96M10.72M7.37M6.20M4.51M4.52M3.52M3.27M3.04M
Goodwill
12.63M12.63M12.63M12.63M12.21M12.21M12.21M12.21M12.21M12.21M12.21M12.21M
Intangibles
31.43M30.64M29.85M29.06M28.27M27.48M26.69M25.90M25.11M24.32M23.53M22.74M21.95M21.16M20.37M14.91M14.29M13.67M13.04M
Goodwill & Intangibles
44.06M43.27M42.48M41.69M40.48M39.69M38.90M38.11M37.32M36.53M35.74M34.95M21.95M21.16M20.37M14.91M14.29M13.67M13.04M
Long-Term Deferred Tax
0.06M
Other Non-Current Assets
0.72M0.80M0.79M0.90M0.85M0.98M1.03M1.01M1.05M0.88M0.89M0.89M0.93M0.88M0.90M0.94M0.93M0.93M0.91M0.92M
Non-Current Assets
10.59M53.95M55.34M58.77M56.86M57.16M61.15M61.35M58.91M57.60M56.35M54.87M54.03M34.59M32.11M29.15M22.42M20.38M19.48M18.62M
Assets
256.57M280.71M286.12M285.06M275.48M270.20M261.82M246.13M229.97M214.51M199.48M186.75M188.69M160.33M142.00M129.56M109.20M98.17M92.14M81.89M
Liabilities
Current Liabilities
Accounts Payables
1.34M2.42M4.66M4.47M2.41M3.75M4.33M2.43M5.14M1.60M1.16M2.56M3.08M2.47M1.36M1.80M0.70M0.35M0.99M0.54M
Payables
1.34M2.42M4.66M4.47M2.41M3.75M4.33M2.43M5.14M1.60M1.16M2.56M3.08M2.47M1.36M1.80M0.70M0.35M0.99M0.54M
Accumulated Expenses
4.40M7.88M7.01M7.26M11.32M8.06M7.01M8.55M11.92M9.21M8.33M10.28M7.97M9.53M7.20M7.36M6.68M6.25M8.69M8.83M
Other Accumulated Expenses
0.35M1.25M1.43M1.01M2.64M0.93M0.64M1.31M
Short term Debt
0.16M
Current Deferred Revenue
0.20M0.18M0.16M0.14M0.11M1.43M0.84M2.04M1.74M1.46M1.52M1.40M1.40M0.32M0.34M
Total Current Liabilities
6.37M11.16M16.48M12.17M14.03M12.24M11.99M12.11M18.57M12.60M12.84M15.59M15.07M15.66M11.98M12.72M10.80M10.02M12.00M11.42M
Non-Current Liabilities
Convertible Debt
Minority Interest
0.49M0.44M0.40M0.37M0.32M0.30M0.27M0.25M0.20M0.21M0.18M0.17M0.17M0.11M0.10M0.10M0.10M0.08M0.08M0.06M
Operating Leases
7.73M6.54M6.40M8.31M8.07M8.34M10.01M11.04M11.20M11.19M10.90M10.65M10.68M10.09M9.96M9.95M9.55M9.26M9.00M8.57M
Non-Current Deferred Tax Liability
0.57M0.46M0.44M0.42M0.39M0.32M0.25M0.24M0.21M
Other Non-Current Liabilities
2.37M2.44M2.73M2.84M1.71M1.71M2.12M1.80M1.82M1.87M1.89M1.61M2.65M2.65M2.54M2.51M2.87M2.96M3.06M
Total Non-Current Liabilities
25.78M30.54M27.56M28.49M25.29M26.54M26.55M32.57M25.69M25.60M28.07M27.62M27.54M23.75M24.54M22.13M21.01M22.71M21.70M
Total Liabilities
14.10M28.15M32.99M30.29M31.33M27.00M28.25M28.67M34.37M27.51M27.47M29.96M29.23M30.19M26.40M27.08M24.64M23.88M25.66M24.76M
Shareholder's Equity
Total Debt
0.16M
Common Equity
242.47M252.56M253.14M254.77M244.15M243.20M233.57M217.46M195.60M187.00M172.02M156.79M159.46M130.13M115.59M102.48M84.56M74.29M66.48M57.13M
Liabilities and Shareholders Equity
256.57M280.71M286.12M285.06M275.48M270.20M261.82M246.13M229.97M214.51M199.48M186.75M188.69M160.33M142.00M129.56M109.20M98.17M92.14M81.89M
Retained Earnings
-93.47M-108.58M-105.99M-90.30M-82.05M-103.24M-121.42M-145.22M-159.30M-176.59M-192.10M-209.01M-217.12M-237.66M-257.31M-278.44M-293.00M-304.09M-309.63M-320.21M

Barinthus Biotherapeutics Balance Sheet API

Pull Barinthus Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BRNS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY